Expression of cardiac muscle markers in rat myocyte cell lines. 1996

G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
Department of Medicine, Loyola University, Maywood, IL 60153, USA.

Recently developed rat heart myocyte cell lines have afforded us the opportunity to evaluate the expression of several transcription factors associated with early cardiac development. These factors include, but are not limited to, Nkx-2.5/Csx, MEF-2C and MLP (Muscle LIM Protein). These factors have been shown to be temporally expressed in pre-cardiac mesenchyme coincident with the earliest stages of heart development. Using the BWEM and CLEM myocyte cell lines as models of the embryonic, committed cardiomyocyte, we have evaluated the basal expression levels of these three genes over multiple passages. Both cell lines express these genes, with MEF-2C being the most abundant based on Northern blot hybridization analyses. Interestingly, as these cells increased their passage number, there was a corresponding increase in their basal expression levels. To evaluate potential 'downstream' effectors of these genes, we examined the basal expression levels of two cardiac-specific genes cTNC and MLC-2v. Transcript levels for both of these contractile filament genes were elevated with passage, suggestive of a inductive process mediated by one or all these three transcription factors. Promoter analysis of MLC-2v expression in the CLEM line shows that this increase is transcriptionally-mediated and the lines retain the necessary regulatory factors to maintain and control the transcription of this gene. Analysis of the dynamics of the regulatory role(s) that these three transcription factors play in cardiac development can now be evaluated in a homogeneous, cell culture system.

UI MeSH Term Description Entries
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D000072576 Homeobox Protein Nkx-2.5 A homeobox-containing transcription factor that functions in heart development. Mutations in the NKX2-5 gene are associated with ATRIAL SEPTAL DEFECTS and TETRALOGY OF FALLOT. Cardiac-Specific Homeobox Protein,Homeobox Protein Csx-Nkx2.5,Homeobox Transcription Factor Csx-Nkx2-5,NK2 Homeobox 5 Protein,Transcription Factor Nkx-2.5,Cardiac Specific Homeobox Protein,Csx-Nkx2.5, Homeobox Protein,Homeobox Protein Csx Nkx2.5,Homeobox Protein Nkx 2.5,Homeobox Protein, Cardiac-Specific,Homeobox Transcription Factor Csx Nkx2 5,Nkx-2.5, Homeobox Protein,Nkx-2.5, Transcription Factor,Transcription Factor Nkx 2.5
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription

Related Publications

G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
September 1991, Human cell,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
January 2015, Biological & pharmaceutical bulletin,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
March 2003, Pharmacology & therapeutics,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
January 1987, The American journal of physiology,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
January 2010, Journal of stem cells & regenerative medicine,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
February 2010, Oncology reports,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
December 1990, American journal of respiratory cell and molecular biology,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
April 2008, Hypertension research : official journal of the Japanese Society of Hypertension,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
January 2016, Circulation research,
G L Engelmann, and R A Worrell, and R A Duff, and P S Grutkoski, and K R Chien, and R P Harvey
December 1986, Journal of the American College of Cardiology,
Copied contents to your clipboard!